Biomedical subjects

C T Germer

Publications and source records attributed to C T Germer.

41 records · Page 3Linked to original sources

PubMed1988

[The esophageal cyst--a rare congenital abnormality].

Esophageal cysts are among the embryonic malformations of the gastrointestinal tract. They develop from persisting diverticulum-like evaginations of the embryonic esophagus. The esophageal cyst is usually asymptomatic and is frequently diagnosed as an incidental finding. Since, however, a clear differentiation from malignancies is not possible with conventional diagnostic procedures. Surgical treatment is advisable in these cases.

Esophageal Cyst↗

PubMed1987

Pathogenesis of the mucosal hyperplasia in self-filling blind loops of rat jejunum: a morphometric study in germ free animals.

Bacterial overgrowth and high intraluminal concentrations of deconjugated bile acids are thought to be responsible for mucosal hyperplasia in self-filling blind loops of rat jejunum. To investigate this hypothesis further we have assessed the three dimensional architecture of these loops created in germ free animals without or with di- or mono-association of different bacterial species. It was found that mucosal hyperplasia develops in the absence of any bacterial contamination and that bacterial association does not lead to a more pronounced mucosal proliferation. This implies that other mechanisms provoke this morphological phenomenon. Increased bulk contents in these loops or immunological events are probably the most likely explanation.

Animals↗

PubMed1985

[Significance of deficient bacterial colonization in the pathogenesis of mucosal lesions in experimental blind loop syndrome].

A complete evaluation of the bacterial flora in jejunal self-filling blind loops was performed. The results show a significant increase in bacteria of the genera E. coli, Streptococcus and Bacteroides. In further experiments, jejunal self-filling blind loops were created in germ-free animals. In spite of the germ-free state the mucosa displayed marked hyperplasia. The same was true when the blind loops had been contaminated with aerobic bacteria. These results demonstrate that other factors in addition to bacterial overgrowth contribute to the mucosal damage observed in self-filling blind loops.

Animals↗

PubMed1985

[Qualitative and quantitative detection of bacterial flora in experimental blind loop syndrome of the rat].

In the blind loop syndrome bacterial overgrowth--accompanied by an increase in bile acid deconjugation--is thought to be responsible for the observed morphological alterations of the small intestinal mucosa with its concomitant malabsorption syndrome. Since in this chain of events the bacterial overgrowth is of primary importance, we have performed a complete qualitative and quantitative evaluation of the intraluminal flora in rats with surgically created self-filling blind loops. The results show a significant increase in bacteria of the aerobic growing genera E. coli and Streptococcus (Enterococcus), and of the anaerobic growing genus Bacteroides, in one single rat also of the genera Lactobacillus/Bifidobacterium. In order to elucidate which strains of bacteria are predominantly responsible for the morphological and functional alterations observed in the stagnant loop syndrome, germ-free rats with self-filling blind loops should be contaminated selectively with bacteria of these genera.

Animals↗

PubMedDate not supplied

Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastases.

BACKGROUND: It is necessary to establish therapeutic regimens for patients with nonresectable hepatic metastases of colorectal carcinoma. A new regional chemotherapy regimen was tested in a prospective study in three centers. PATIENTS AND METHODS: An arterial port system was implanted in 95 patients. From January 1994 to March 1999, intra-arterial treatment was applied via the hepatic artery using 450 mg starch microspheres with 5 million IU recombinant interferon-alpha 2B, 500 mg/m2 folinic acid and 600 mg/m2 5-FU body surface for 5 days with a 14-day interval. RESULTS: The tumor response rate was 70%. Median disease progression was 17 months, median survival 24 months. The subgroup analysis shows a significant advantage (p<0.00001) for patients with a liver tumor involvement of <25% and a median survival of 39 months compared to a tumor involvement of 25-50% (24 months) and >50% (14 months). Major toxicity problems were observed in 11%. However, there was no termination of therapy on account of these problems. CONCLUSION: Intra-arterial chemotherapy with our new regimen was useful in patients with colorectal liver metastases who had only an intrahepatic tumor burden of <50%.

Adenocarcinoma↗